NO981898D0 - Anvendelse av flupirtin for forhindring og behandling av sykdommer som er forbundet med skade pÕ det hematopotiske cellesystem - Google Patents

Anvendelse av flupirtin for forhindring og behandling av sykdommer som er forbundet med skade pÕ det hematopotiske cellesystem

Info

Publication number
NO981898D0
NO981898D0 NO981898A NO981898A NO981898D0 NO 981898 D0 NO981898 D0 NO 981898D0 NO 981898 A NO981898 A NO 981898A NO 981898 A NO981898 A NO 981898A NO 981898 D0 NO981898 D0 NO 981898D0
Authority
NO
Norway
Prior art keywords
flupirtine
treatment
cell system
diseases associated
hematophotic
Prior art date
Application number
NO981898A
Other languages
English (en)
Other versions
NO981898L (no
NO315074B1 (no
Inventor
Gabriela Pergande
Werner E G Mueller
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO981898L publication Critical patent/NO981898L/no
Publication of NO981898D0 publication Critical patent/NO981898D0/no
Publication of NO315074B1 publication Critical patent/NO315074B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19981898A 1995-11-07 1998-04-27 Anvendelse av flupirtin for fremstilling av legemidler for behandling av indusert apoptotisk celledöd av lymfocytter NO315074B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541405A DE19541405A1 (de) 1995-11-07 1995-11-07 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
PCT/DE1996/002009 WO1997017072A2 (de) 1995-11-07 1996-10-23 Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen

Publications (3)

Publication Number Publication Date
NO981898L NO981898L (no) 1998-04-27
NO981898D0 true NO981898D0 (no) 1998-04-27
NO315074B1 NO315074B1 (no) 2003-07-07

Family

ID=7776799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981898A NO315074B1 (no) 1995-11-07 1998-04-27 Anvendelse av flupirtin for fremstilling av legemidler for behandling av indusert apoptotisk celledöd av lymfocytter

Country Status (27)

Country Link
US (2) US6034111A (no)
EP (1) EP0859613B1 (no)
JP (1) JPH11514652A (no)
KR (1) KR100512673B1 (no)
CN (1) CN1116037C (no)
AT (1) ATE316789T1 (no)
AU (1) AU711207B2 (no)
BG (1) BG63149B1 (no)
BR (1) BR9611588A (no)
CA (1) CA2189705C (no)
CZ (1) CZ298115B6 (no)
DE (2) DE19541405A1 (no)
DK (1) DK0859613T3 (no)
ES (1) ES2257755T3 (no)
HK (1) HK1016508A1 (no)
HU (1) HU225742B1 (no)
MX (1) MX9803610A (no)
NO (1) NO315074B1 (no)
NZ (1) NZ330414A (no)
PL (1) PL186537B1 (no)
PT (1) PT859613E (no)
RU (1) RU2200555C2 (no)
SK (1) SK284601B6 (no)
TW (1) TW393317B (no)
UA (1) UA51682C2 (no)
WO (1) WO1997017072A2 (no)
ZA (1) ZA968783B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
WO2011017495A1 (en) * 2009-08-07 2011-02-10 Swagelok Company Low temperature carburization under soft vacuum
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2013127539A2 (de) * 2012-03-02 2013-09-06 Meda Pharma Gmbh & Co. Kg Pharmazeutische formulierungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172468B (no) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Also Published As

Publication number Publication date
DE19541405A1 (de) 1997-05-15
CN1201391A (zh) 1998-12-09
KR19990067366A (ko) 1999-08-16
CA2189705C (en) 2005-08-09
KR100512673B1 (ko) 2005-12-09
PL326629A1 (en) 1998-10-12
HU225742B1 (en) 2007-07-30
WO1997017072A2 (de) 1997-05-15
SK284601B6 (sk) 2005-07-01
MX9803610A (es) 1998-09-30
CZ298115B6 (cs) 2007-06-27
ES2257755T3 (es) 2006-08-01
EP0859613B1 (de) 2006-02-01
BR9611588A (pt) 1999-04-06
SK58698A3 (en) 1998-09-09
CN1116037C (zh) 2003-07-30
US6034112A (en) 2000-03-07
JPH11514652A (ja) 1999-12-14
HUP9901659A2 (hu) 1999-09-28
AU1716597A (en) 1997-05-29
NZ330414A (en) 1999-10-28
NO981898L (no) 1998-04-27
NO315074B1 (no) 2003-07-07
CA2189705A1 (en) 1997-05-08
UA51682C2 (uk) 2002-12-16
ATE316789T1 (de) 2006-02-15
EP0859613A2 (de) 1998-08-26
RU2200555C2 (ru) 2003-03-20
US6034111A (en) 2000-03-07
CZ128398A3 (cs) 1998-09-16
DE59611327D1 (de) 2006-04-13
HK1016508A1 (en) 1999-11-05
ZA968783B (en) 1997-05-27
PL186537B1 (pl) 2004-01-30
BG102404A (en) 1998-12-30
AU711207B2 (en) 1999-10-07
WO1997017072A3 (de) 1997-07-24
TW393317B (en) 2000-06-11
DK0859613T3 (da) 2006-06-06
HUP9901659A3 (en) 2001-04-28
PT859613E (pt) 2006-06-30
BG63149B1 (bg) 2001-05-31

Similar Documents

Publication Publication Date Title
TR199903053T2 (xx) Benzimidazol t�revleri.
MY117892A (en) Therapeutic compounds
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
SE9101815L (sv) Behandling av sjukdom foerbunden med hiv-infektioner
NO981898L (no) Anvendelse av flupirtin for forhindring og behandling av sykdommer som er forbundet med skade pÕ det hematopotiske cellesystem
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
NO962000L (no) Prolegemidler av en inhibitor av HIV-protease
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
HUP0203682A2 (hu) Eljárás foszfodiészteráz-4 inhibitor beadására
AP9801286A0 (en) Therapeutic compounds.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
NZ512850A (en) Treatment of papillomavirus infections
NO20002481L (no) Kombinasjonsterapi for behandling av AIDS
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
AU2396900A (en) Treatment and prevention of hiv and other viral infections
DK0910405T3 (da) Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion
DK0728002T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
DK0545991T3 (da) Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf
AU2211592A (en) Method of treatment for latent virus infection
DK0728001T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees